Pituitary and Neuroendocrine

Immune Checkpoint Inhibitor-Mediated Endocrinopathies: A Consensus Statement

American Association of Clinical Endocrinology Disease State Clinical Review - Evaluation and Management of Immune Checkpoint Inhibitor-Mediated Endocrinopathies: A Practical Case-Based Clinical Approach

Kevin C. J.

Adrenal, Pituitary and Neuroendocrine, Reproductive and Gonad, Thyroid

AACE Position Statement on Off-Label Use and Misuse of Testosterone, Growth Hormone, Thyroid Hormone, and Adrenal Supplements: Risks and Costs of a Growing Problem

Off-label use and misuse of testosterone, GH, thyroid hormone, and adrenal supplements have become increasingly prevalent. Many patients seek treatment for common nonspecific symptoms such as fatigue, low energy, poor sleep, weight gain, and lower libido.

Bone and Parathyroid

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Quality of DXA Scans and Reports

Angelo A. Licata, Neil Binkley, Steven M. Petak and Pauline M. Camacho

Endocrine Practice 

Feb 2018, Vol. 24, No. 2 (February 2018) pp. 220-229


Position Statement on the Use of Vitamins and Minerals in Skeletal Health (2018)

The desire to maintain health, including bone health, into old age has led to almost one-half of the population and 70% of older adults in the United States and up to 26% in Europe using dietary supplements. Dietary supplements allow for randomized controlled trials (RCTs) that can assess a single nutrient.


AACE/ACE Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis © 2016

Recent reports of diabetic ketoacidosis (DKA) occur-ring in conjunction with sodium glucose-cotransporter 2 (SGLT-2) inhibitor therapy have raised concerns that these agents may increase the risk of DKA, especially among patients taking exogenous insulin. On May 15, 2015, the U.S.

Diabetes and Cancer - An AACE/ACE Consensus Statement © 2013

AACE convened a conference to review factors associated with cancer development in people with obesity and diabetes and to discuss the possible cancer risk of antihyperglycemic medications.

ACE/AACE Consensus Conference on the Implementation of Outpatient Management of Diabetes Mellitus: Consensus Conference Recommendations © 2006

Among the more than 20 million Americans whohave diabetes, approximately 30% of the cases are undi-agnosed (1). An additional 42 million people in the UnitedStates have pre-diabetes (impaired glucose tolerance[IGT], impaired fasting glucose, or both), a condition thatoften leads to diabetes if it is not treated (1).

Transcultural Diabetes care in the United States

A position statement by the American Association of Clinical Endocrinologists

Nutrition and Obesity

Consensus Conference on Obesity: Building an Evidence Base for Comprehensive Action (2014)

This statement outlines the key findings from the 2014 AACE/ACE Consensus Conference on Obesity.

Position Statement on Obesity and Obesity Medicine (2012)

This statement outlines AACE's position regarding obesity as a disease with multiple pathophysiological aspects, including genetic, environmental, physiological, and psychological factors. It sets the framework for future efforts to advance its treatment and prevention.

Adiposity-Based Chronic Disease as a New Diagnostic Term: The AACE/ACE Position Statement © 2017

The American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) have created a chronic care model, advanced diagnos-tic framework, clinical practice guidelines, and clinical practice algorithm for the comprehensive management of obesity.

AACE Position Statement on Clinical Nutrition and Health Promotion in Endocrinology 2012

The discipline of clinical nutrition is spread over a diverse array of medical and surgical specialties. Many medical societies report both a significant decrease in and an inadequate number of physician members trained in nutrition at a time when the prevalence of many nutrition-related medical conditions is escalating (1,2).

AACE Medical Guidelines for the Clinical Use of Dietary Supplements and Nutraceuticals © 2003

Few topics in medicine are more controversial than the use of alternative care methods including dietary supplements and nutraceuticals. Because endocrinologists frequently encounter issues involving DS/N, the information in this report should be helpful.

Lipids and CV Health

The Clinical Approach to the Detection of Lipodystrophy - An AACE Consensus Statement © 2013

Lipodystrophy is a rare, heterogeneous group of syndromes characterized by the complete or partial loss or absence of subcutaneous adipose tissue (1,2).

Adrenal, Bone and Parathyroid, Diabetes, Endocrine Surgery, Lipids and CV Health, Nutrition and Obesity, Pituitary and Neuroendocrine, Reproductive and Gonad, Thyroid

Transculturalization Recommendations for Developing Latin American Clinical Practice Algorithms in Endocrinology

Evidence-based medicine has generated many philosophical and pragmatic challenges to clinical care. Chief among these challenges is how to deliver culturally appropriate individualized endocrine care while adhering to evidence-based guidelines and algorithms developed for large heterogeneous populations.

Position Statement on Healthcare Disparities © 2012

Since its inception, the American Association of Clinical Endocrinologists (AACE) has advocated for the finest in endocrine education and state-of-the-art health-care delivery without regard to race, ethnicity, gender, age, country of origin, economic status, lifestyle, sexual orientation or domestic living arrangements.

Reproductive and Gonad

AACE/ACE Position Statement on the Association of Testosterone and Cardiovascular Risk © 2015

Several recent publications have raised concern that testosterone therapy in men increases cardiovascular risks. Media reports declared that testosterone therapy is dangerous, without addressing the scientific validity of these studies.

AACE/ACE Position Statement On Menopause © 2017

The most recent American Association of Clinical Endocrinologists (AACE)/American College of Endocrinology (ACE) clinical practice guidelines for the treatment of menopause was published in 2011 (1).